Latest Safety News

South32 reported a robust US$360 million net profit for H1 FY25, driven by strong commodity prices and operational execution, while investing heavily in growth projects like Hermosa and returning US$169 million to shareholders.

Orora Limited reported a robust first half of FY25 with underlying EBIT rising 24.6%, driven by strategic portfolio simplification and organic growth investments despite challenges in the Australian wine market.

South32 Limited reported a strong first half of fiscal 2025, driven by improved operational performance and a streamlined portfolio following the sale of Illawarra Metallurgical Coal. The company announced a fully-franked interim dividend and maintained its production guidance despite some operational challenges.

Northern Star Resources has reported a remarkable 155% surge in net profit for the half year ended December 2024, driven by higher gold prices and solid operational output. The company also announced a 25 cent per share interim dividend, underscoring confidence in its financial strength.

Riversgold Ltd is set to commence its 2025 drilling campaign at the Northern Zone gold project near Kalgoorlie, following a series of promising high-grade gold intercepts and a mining lease application.

Alliance Aviation Services reported an 11.3% revenue increase to $333 million and a 9.9% rise in net profit to $28.9 million for H1 FY2025, navigating challenges from industrial action and contract reductions.

Cycliq Group Limited reported an 18% revenue increase to $2.9 million for the half-year ending December 2024, driven by higher transaction values and a revamped marketing strategy, despite a modest net loss of $211,214.

RareX has finalized a critical access agreement with Deep Yellow and secured two additional licenses, enabling a fully optimised drilling program targeting carbonatite intrusions at the Khaleesi Project.

Beacon Minerals has secured key regulatory approvals to launch multiple drilling programs at its Lady Ida Iguana Project, setting the stage for intensified exploration activity over the coming months.

Island Pharmaceuticals has successfully completed patient dosing in the Phase 2b therapeutic arm of its PROTECT clinical trial for ISLA-101, targeting dengue fever treatment. High-level results are expected within two months, potentially advancing a significant antiviral candidate.

AGL Energy reported a solid first half of FY25 with underlying EBITDA slightly down but maintained strong operational momentum, while narrowing its full-year earnings guidance and announcing key leadership changes.

Evolution Mining has reported a landmark first half of FY25 with a 277% jump in statutory net profit and a substantial 250% increase in its interim dividend, underscoring robust operational momentum and shareholder returns.